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P U B L I S H E D B Y E L S E V I E R I N C .LettersEffect of Patent Foramen
Ovale Closure on
Obstructive Sleep ApneaPatent foramen ovale (PFO) is a prevalent embryo-
logic remnant with insufﬁcient post-natal adhesion of
the cardiac atrial septum primum and secundum.
Among many other conditions, it has been associated
with obstructive sleep apnea (OSA) syndrome. The
mechanism operative in these conditions is tempo-
rary right-to-left atrial shunting across the “open
door” of the septum primum, which leads to short
bouts of arterial de-oxygenation. The effect of PFO
closure on OSA has not been investigated to date. We
tested whether PFO closure in OSA patients led to a
lowering of the apnea–hypopnea index (AHI) and to
improved cardiovascular function.
This prospective open-label study included 40
consecutive patients with newly diagnosed OSA.
Fourteen of them had PFOs diagnosed by trans-
esophageal contrast echocardiography; these patients
underwent initial device closure. Twenty-six patients
did not have PFOs. Conventional treatment for OSA
was postponed for 3 months in both groups, and pol-
ysomnographic and cardiovascular examinationswere
performed at baseline and at the end of the follow-up
period. The following endpoints were compared
intra- and interindividually: AHI (primary endpoint);
oxygen de-saturation index (ODI) (drops in oxygen
saturation >3% points per hour); systemic arterial
blood pressure; and Doppler echocardiographic pa-
rameters. During follow-up, AHI decreased from38.6
16.0 to 30.4  16.1 events per hour in the PFO closure
group (p ¼ 0.0034), and it changed from 33.9  29.8 to
38.6  26.2 events per hour in the no PFO group (p ¼
0.29) (Figure 1). AHI change (follow-up minus baseline
value) differed signiﬁcantly between the groups: –7.9
 10.4 in the PFO closure group andþ4.7 13.1 in the no
PFO group (p ¼ 0.0009). The following parameters
improved signiﬁcantly in the PFO closure group,
whereas they remained unchanged in the no PFO
group: ODI; a decrease in nocturnal systolic blood
pressure (Figure 1) and daytime blood pressure; right
ventricular-to-right atrial systolic pressure gradient
(Figure 1); and left ventricular diastolic function.This ﬁrst clinical investigation on the effect of PFO
closure on OSA found a reduction of approximately
8 AHI events per hour in response to PFO closure.
This reduction was accompanied by a mitigated ODI,
by a nocturnal systemic blood pressure reduction of
5 mm Hg, and by lowered pulmonary pressure values
with enhanced left ventricular diastolic function.
A causal relation between PFO and OSA would be
evident if a positive effect on OSA of PFO closure
could be systematically documented. So far, the efﬁ-
cacy of PFO closure on OSA parameters has only been
implied in case reports (1–3).
Pathophysiologically, PFO appears to have an
exacerbating effect on phasic breathing in OSA. The
crucial element in this context is short events of atrial
right-to-left shunts with ensuing episodes of hypox-
emia, which aggravate the already disturbed central
breathing regulation in OSA. The initiating incident in
the cascade of phasic breathing in OSA is the ﬁrst ap-
nea in the context of muscular relaxation during rapid
eyemovement sleep. Rising arterial pressure of carbon
dioxide (PCO2) in the context of this apnea induces
breathing efforts against the closed glottis, which
brieﬂy elevates right atrial pressure above left atrial
pressure and leads to shunting of de-oxygenated
blood to the systemic side in cases of a PFO. Hypox-
emia impairs endothelial function in the pulmonary
and in the systemic circulation, and it acts as a central
respiratory stimulant, which inﬂuences the PCO2-
steered respiratory regulation differently from other
stimulants (4). Hypoxemia lowers the eupneic PCO2
level in the context of hyperventilation without
concomitant reduction in the apneic PCO2 threshold,
thus destabilizing the system and rendering it more
prone to ensuing apnea phases (4). In this scenario, the
elevated sympathetic tone with increased systemic
blood pressure is related to the events of arousal at the
end of the apnea phases. Our study results support this
concept by showing a normalization of the estimated
pulmonary pressure in response to PFO closure,
together with augmented diastolic function of the left
ventricle and reduced nocturnal systolic blood
pressure.
The main study limitations are the nonrandomized
design, which was appropriate in the context of this
ﬁrst-in-man study, the low number of patients
included, and the lack of female patients.
FIGURE 1 Individual Changes in Apnea–Hypopnea Index and
Systolic Blood Pressure Obtained at Baseline and at the
3-Month Follow-Up Examination in Patients With and
Without PFO
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Individual changes in the apnea–hypopnea index (upper panel)
obtained at baseline and at the 3-month follow-up examination
in patients with patent foramen ovale (PFO) and in patients
without PFO. Changes in nocturnal systolic blood pressure and in
transtricuspid right ventricular (RV) to right atrial (RA) systolic
pressure gradient (middle and lower panels) at baseline and at
the 3-month follow-up examination in patients with and without
PFO. Error lines indicate mean  SD.
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269–78.Emergency Department
Management of
Atrial Fibrillation in the
United States Versus
Ontario, CanadaSurvey data suggest that there is considerable inter-
national variation in the emergency department (ED)
management of patients with atrial ﬁbrillation (AF)
(1–3). Hospitalization is common in the United States
(2), where nearly 70% of ED visits for AF end in
hospitalization (2,3); this has remained constant
since 2000 (2,3). By comparison, in Canada’s most
populous province <40% of individual AF patients
were admitted in 2010 (1), which had dropped by 10%
since 2002 (1). However, no direct intercountry com-
parisons have been published. Our objective was to
directly compare ED AF visits and their associated
management strategies in the United States and the
province of Ontario, Canada.
We conducted a cross-sectional study of ED visits
with a primary diagnosis of AF between January 1,
2007, and December 31, 2009, in the U.S. Nationwide
Emergency Department Sample (NEDS) and the
